Catamaran Corporation

Last updated
Catamaran Corporation
Type Public
TSX: CCT
Nasdaq: CTRX
Industry PBM and Health informatics
PredecessorSXC Health Solutions
Founded1993;29 years ago (1993) (as SXC Health Solutions)
DefunctJuly 23, 2015 (2015-07-23)
FateAcquired
Successor UnitedHealth Group
Headquarters,
Key people
Terrece C Burke Chair
Mark A. Thierer (CEO)
Revenue $14,780.094 milIncrease2.svg49% 2013 [1]
$287.739 milIncrease2.svg138% 2013 [1]
Total assets $7,995.763 milIncrease2.svg8% 2013 [1]
Total equity $4,908.490 milIncrease2.svg6% 2013 [1]
Number of employees
4,000 (Dec. 31, 2013) [1]
1,433 (Dec. 31, 2011)
1,216 (Feb. 25, 2011) [2]
Divisions informedRx
Healthcare IT Group
HBS Health Business Systems
Website www.catamaranrx.com

Catamaran Corporation (formerly SXC Health Solutions) is the former name of a company that now operates within UnitedHealth Group's OptumRX division (since July 2015). It sells pharmacy benefit management and medical record keeping services to businesses in the United States [3] and to a broad client portfolio, including health plans and employers. [4] Working independently of the government and insurance companies allowed it to operate as a third party verifier; the RxCLAIM online claim processing system allowed for prescription drug claims to be processed online if the customer lived in and filled his/her prescription in the United States. SXC had three separate but interrelated business segments which dealt with prescription drug programs. For 2013, 23% of company revenue came from Cigna Corporation. [5]

Contents

Most of the company's growth came in 2008 when it doubled in size; between 2005 and 2010 revenue increased 3,400%. [6] As a Canadian startup, the company received venture capital subsidies from the Canadian government in addition to private investments. These subsidies allowed the business to grow initially and establish its business model in advance of its initial public offering, which was offered through the NASDAQ exchange in 2009. The success of the mixed public and private approach in SXC's case has been called "perhaps the best example of the flexibility and the value added by the Canadian hybrid system." [7] In 2013 company revenue increased by 49% thanks to a full year of prescription claims at the Catalyst division, and additional volumes from newly acquired Restat. [5] On March 30, 2015, it was announced that Catamaran will be acquired by OptumRx (A UnitedHealth Group company). [8]

History

Systems Xellence (SXC), founded in 1993, was a Canadian company that first went public in 1995 when it joined the TSX. Six years later, in 2001, it acquired ComCoTec, an Illinois-based software business. [9] [10] After going public on the NASDAQ stock market in 2006, the company shifted its headquarters from Milton, Ontario to Chicago, the city ComCoTec was based in. SXC was one of the first companies to build technology used in pharmacy benefit management. [6] [11] [12] [13] [14] [15]

In February 2008, eight months after the company changed its name to SXC Health Solutions, it acquired National Medical Health Card Systems, Inc. (NMHC) for US$143 million in a move that doubled its size and workforce. [16] [17] It is now known as InformedRx, a division of SXC. [18] On December 19, 2008, the company also acquired Zynchros, an eight-year-old Seattle-based formulary management business. [19]

SXC purchased private company MedfusionRx, Inc on December 2, 2010 for $100 million. Reasons for the acquisition include an interest in strengthening SXC's position in the speciality pharmacy market and improving cost cutting capabilities in the management of complex conditions and improving supportive care. [20] MedfusionRx provides voice messaging services to people in all 50 US states as well as other clinical services to over 9000 patients. The messages have to do with medical treatment assistance including the delivery and refill reminders of medication and patient monitoring for people with chronic diseases. It was founded in 2003 in Birmingham, Alabama. Medfusion manages $270 million in drug spending. [20]

In 2012, SXC agreed to buy rival Catalyst Health Solutions Inc. in a roughly $4.14 billion cash-and-stock deal. [21] Shortly thereafter, SXC Health Solutions Corp. renamed the company, Catamaran Corp. [22]

In 2015, health insurer UnitedHealth Group agreed to buy pharmacy benefit manager Catamaran Corp in a deal worth about $12.8 billion. [23]

Business segments

SXC has three main business segments: InformedRx, Healthcare IT Group (HCIT), and Health Business Systems.

InformedRx is SXC Health Solution's pharmacy benefit management service. It deals with formulary administration, benefit plan design and management, pharmacy network management, drug utilization review, clinical services and consulting, reporting and information analysis, mail services and specialty pharmacy, and consumer web services.

Healthcare IT Group focuses on the technological aspects of the company. It includes the RxCLAIM, RxTRACK, and RxPORTAL customer interfaces, which support the electronic processing of prescriptions. It also includes pharmacy technology services (technology relied upon by application service providers), as well as Zynchros, a provider of formulary management tools.

Health Business Systems are management systems providers to retail, institutional or nursing home, and mail order pharmacy environments.

Customers

SXC Health Solutions has been used by various organizations, including Cigna, [24] HealthSpring, PharMerica, TennCare, the Boston Medical Center HealthNet Plan, and Health Alliance of Michigan.

Related Research Articles

McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 78,000 employees. McKesson had revenues of $238.2 billion in its fiscal year ending March 31, 2021.

Medco Health Solutions, Inc. was an American Pharmacy Benefits Management (PBM) company. Medco provided pharmacy services to private and public employers, health plans, labor unions, government agencies and individuals served by Medicare Part D Prescription Drug Plans.

UnitedHealth Group Incorporated is an American multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services. UnitedHealth Group is the world's seventh largest company by revenue and the largest healthcare company by revenue, and the largest insurance company by net premiums. UnitedHealthcare revenues comprise 80% of the Group's overall revenue.

Express Scripts Holding Company is a pharmacy benefit management (PBM) organization. In 2017 it was the 22nd-largest company in the United States by total revenue as well as the largest pharmacy benefit management (PBM) organization in the United States. Express Scripts had 2016 revenues of $100.752 billion. Since December 20, 2018, the company has been a direct subsidiary of Bloomfield, Connecticut-based Cigna.

TELUS Health, a division of TELUS Communications Inc, is a Canadian provider of digital health technology and services with close to 3,000 employees. Based in Montreal, Quebec with offices in Quebec, Ontario, Alberta, and British Columbia[1] the company is committed to create a more digitized and connected health ecosystem allowing for more information sharing and facilitating collaboration between health professionals in order to improve health experience for people living in Canada. Its wide range of products and services is intended for Canadian consumers, employers, insurers, healthcare professionals, health institutions and governments.

CVS Caremark is the prescription benefit management subsidiary of CVS Health, headquartered in Woonsocket, Rhode Island.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

<span class="mw-page-title-main">First Databank</span>

First Databank (FDB) is a major provider of drug and medical device databases that help inform healthcare professionals to make decisions. FDB partners with information system developers to deliver useful medication- and medical device-related information to clinicians, business associates, and patients. FDB is part of Hearst and the Hearst Health network.

Electronic prescription is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy. It outlines the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of the major reasons for the push for electronic medical records. By sharing medical prescription information, e-prescribing seeks to connect the patient's team of healthcare providers to facilitate knowledgeable decision making.

Allscripts Healthcare Solutions, Inc. is a publicly traded American company that provides physician practices, hospitals, and other healthcare providers with practice management and electronic health record technology. Allscripts also provides products for patient engagement and care coordination, as well as financial and analytics technology. The company has more than 180,000 physician users and has products in 2,700 hospitals and 13,000 extended care organizations.

<span class="mw-page-title-main">Universal American</span>

Universal American is a Fortune 500 company with offices throughout the United States, and headquarters in Rye Brook, New York. The company offered health insurance, and also deals in Medicare managed care plans, and Medicare prescription drug benefits. Its CEO is Richard A. Barasch.

Change Healthcare is a provider of revenue and payment cycle management that connects payers, providers, and patients in the U.S. healthcare system. The name also refers to a company founded in 2007 which subsequently became part of the current conglomerate. The company operates the largest financial and administrative information exchange in the United States.

EMIS Health, formerly known as Egton Medical Information Systems, supplies electronic patient record systems and software used in primary care, acute care and community pharmacy in the United Kingdom. The company is based in Leeds. It claims that more than half of GP practices across the UK use EMIS Health software and holds number one or two market positions in its main markets. In June 2022 the company was acquired by Bordeaux UK Holdings II Limited, an affiliate of UnitedHealth’s Optum business for a 49% premium on EMIS’s closing share price.

Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused. They are used to treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease and hepatitis C. In 1990 there were 10 specialty drugs on the market, in the mid-1990s there were fewer than 30, by 2008 there were 200, and by 2015 there were 300. Drugs are often defined as specialty because their price is much higher than that of non-specialty drugs. Medicare defines any drug for which the negotiated price is $670 per month or more, as a specialty drug which is placed in a specialty tier that requires a higher patient cost sharing. Drugs are also identified as specialty when there is a special handling requirement or the drug is only available via a limited distributions network. By 2015 "specialty medications accounted for one-third of all spending on drugs in the United States, up from 19 percent in 2004 and heading toward 50 percent in the next 10 years", according to IMS Health, which tracks prescriptions. According to a 2010 article in Forbes, specialty drugs for rare diseases became more expensive "than anyone imagined" and their success came "at a time when the traditional drug business of selling medicines to the masses" was "in decline". In 2015 analysis by The Wall Street Journal suggested the large premium was due to the perceived value of rare disease treatments which usually are very expensive when compared to treatments for more common diseases.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

Diplomat Pharmacy, Inc. is the largest independent provider of specialty pharmacy services in the United States. The company partners with manufacturers, payers, providers, hospitals, and more. Headquartered in Flint, Michigan, Diplomat has facilities across the United States and dispenses drugs in all 50 states. Diplomat offers specialized medication and medication management programs for patients with complex and chronic conditions such as cancer, hepatitis, multiple sclerosis, HIV and others.

<span class="mw-page-title-main">DST Systems</span>

DST Systems, Inc. is an American company that was acquired by SS&C Technologies in 2018. The company provided advisory, technology and operations outsourcing services to the financial services and healthcare industries. It was founded in February 1969 as Data·Sys·Tance, a subsidiary of Kansas City Southern Industries (KCSI) and is headquartered in Kansas City, Missouri, United States. As of 2016, DST employed 13,420 people worldwide.

Optum, Inc. is an American pharmacy benefit manager and health care provider. It is a subsidiary of UnitedHealth Group since 2011. UHG formed Optum by merging its existing pharmacy and care delivery services into the single Optum brand, comprising three main businesses: OptumHealth, OptumInsight and OptumRx. In 2017, Optum accounted for 44 percent of UnitedHealth Group's profits and as of 2019, Optum's revenues have surpassed $100 billion. Also in early 2019, Optum gained significant media attention regarding a trade secrets lawsuit that the company filed against former executive David William Smith, after Smith left Optum to join Haven, the joint healthcare venture of Amazon, JPMorgan Chase, and Berkshire Hathaway.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

References

  1. 1 2 3 4 5 "Alexion Pharmaceuticals 2013 Annual Report" (PDF). February 2014. Archived from the original (PDF) on 2014-05-18. Retrieved 2015-01-10.
  2. "SXC Health Solutions Corp. info by hoovers".
  3. "SXC Health Solutions and HealthSpring sign PBM contract". 2010-03-04.
  4. "Catamaran and OptumRx to Combine - UnitedHealth Group". www.unitedhealthgroup.com. Retrieved 2020-04-16.
  5. 1 2 "catamaran 2013 report". Archived from the original on 2015-01-10. Retrieved 2015-01-10.
  6. 1 2 Lorinc, John (December 1, 2010). "Cashing in on the U.S. drug craze (The Globe and Mail)". Toronto.
  7. "10 Moments in Canadian Tech Stock History that Changed the World SXC Health goes Public.". 2010-03-31.
  8. "UHGMerger". Wall Street Journal. 2015-03-30.
  9. "sxc health solutions tailor fit". 2008-05-31.
  10. "cantech letter: Ranking Canada's Tech's" (PDF). September 25, 2010. Archived from the original (PDF) on October 3, 2011.
  11. "SXC Health Solutions: Built for Growth". 2009-06-01.
  12. "University of Toledo" (PDF). 2010.
  13. "SXC Health Solutions Transforms Interactions with Pharmaceutical Supply Chain Using Sterling Business Integration Suite". 2009-04-28.
  14. "SXC Health Solutions receives 2007 Rx Benefit Innovation Award". 2007.
  15. "Rx Benefit Innovation Awards Program". 2010. Archived from the original on 2010-08-01.
  16. "Making SXC Health Solutions a 'dominant player' (Chicago Business)". 2008-08-28.
  17. "SXC Health Solutions to acquired NMHC". 2008-02-26.
  18. "informedRx private company information" . Retrieved 2010-04-29.
  19. "SXC Health Solutions acquires Zynchros Inc". 2008-12-22.
  20. 1 2 "SXC Health buys U.S. pharmacy provider MedrusionRx for $100 million". 2010-12-02.
  21. Kamp, Jon (2012-04-18). "Drug Plan Manager SXC to Buy Catalyst". Wall Street Journal.
  22. "SXC to rebrand as Catamaran Corp". Crain's Chicago Business. 3 July 2012.
  23. "UnitedHealth to buy pharmacy benefit firm Catamaran for $12.8 billion". Reuters. March 30, 2015. Retrieved March 30, 2015.
  24. "Archived copy" (PDF). Archived from the original (PDF) on 2015-02-13. Retrieved 2014-12-01.{{cite web}}: CS1 maint: archived copy as title (link)